 |
인쇄하기
취소
|
KFDA suggests strict sealing process
The Korea Food and Drug Administration suggested that some of multinational drug manufacturers observe the sealing regulation of drugs before their release to pharmacies.
The Korean Pharmaceutical Association said that six medicines, including Sanofi-Aventis Rodozyl (spiramycin + metronidazone), Boehringer Ingelheim’s Micardis Plus (telmisartan), and Pfizer’s Crebrex (celecoxib), have been s...
The Korean Pharmaceutical Association said that six medicines, including Sanofi-Aventis Rodozyl (spiramycin + metronidazone), Boehringer Ingelheim’s Micardis Plus (telmisartan), and Pfizer’s Crebrex (celecoxib), have been s...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.